Traded Value
OptionsGood news only comes after Xiao Gu cuts his losses
It may not be good news🤔 Novo should consider withdrawing the weight-loss drug from the US market. After withdrawal, generic drugs will be reclassified as counterfeit drugs.$Novo Nordisk AS(NVO.US)
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments